IT
Innovac Therapeutics is a biotechnology firm that develops mRNA‑based vaccines targeting diseases with unmet medical needs. Leveraging its proprietary RNA platform and in‑house manufacturing capabilities, the company designs and produces vaccine candidates for clinical evaluation. Revenue is generated through partnerships, licensing agreements, and eventual product sales upon regulatory approval.
Updated 4 months ago
Funding
$18M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Innovac Therapeutics is a biotechnology firm that develops mRNA‑based vaccines targeting diseases with unmet medical needs. Leveraging its proprietary RNA platform and in‑house manufacturing capabilities, the company designs and produces vaccine candidates for clinical evaluation. Revenue is generated through partnerships, licensing agreements, and eventual product sales upon regulatory approval.